Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

GFORCE-PD still going strong in 2016

Parmar, Malin LU orcid ; Takahashi, Jun ; Studer, Lorenz and Barker, Roger A LU (2017) In npj Parkinson's Disease 3.
Abstract
In 2014, a new initiative was undertaken by groups working on plans for the transplantation of stem-cell-based derived dopaminergic neurons for treating Parkinson’s disease patients. This GForce-PD group held its annual meeting on 18–19 April 2016 in Chicago at Rush University to discuss their progress and the challenges that the translation of this experimental therapy still faces. Over 2 days, the key issues were discussed around the cell lines that will be used, the differentiation protocols, preclinical testing, GMP-adaptation, and cell manufacturing to allow first in human clinical trials, which are anticipated to start in 2017–2018. GForce-PD members also discussed how they can improve outreach and be of better service to the... (More)
In 2014, a new initiative was undertaken by groups working on plans for the transplantation of stem-cell-based derived dopaminergic neurons for treating Parkinson’s disease patients. This GForce-PD group held its annual meeting on 18–19 April 2016 in Chicago at Rush University to discuss their progress and the challenges that the translation of this experimental therapy still faces. Over 2 days, the key issues were discussed around the cell lines that will be used, the differentiation protocols, preclinical testing, GMP-adaptation, and cell manufacturing to allow first in human clinical trials, which are anticipated to start in 2017–2018. GForce-PD members also discussed how they can improve outreach and be of better service to the Parkinson's disease (PD) community and help them to make the best possible decisions when pursuing stem cell treatments. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
npj Parkinson's Disease
volume
3
article number
16014
publisher
Springer Nature
external identifiers
  • scopus:85060614515
ISSN
2373-8057
DOI
10.1038/npjparkd.2016.14
language
English
LU publication?
yes
id
26a9bb38-82c4-4e20-93ef-f09a4e032e05
date added to LUP
2019-09-20 11:41:55
date last changed
2022-02-16 00:09:38
@article{26a9bb38-82c4-4e20-93ef-f09a4e032e05,
  abstract     = {{In 2014, a new initiative was undertaken by groups working on plans for the transplantation of stem-cell-based derived dopaminergic neurons for treating Parkinson’s disease patients. This GForce-PD group held its annual meeting on 18–19 April 2016 in Chicago at Rush University to discuss their progress and the challenges that the translation of this experimental therapy still faces. Over 2 days, the key issues were discussed around the cell lines that will be used, the differentiation protocols, preclinical testing, GMP-adaptation, and cell manufacturing to allow first in human clinical trials, which are anticipated to start in 2017–2018. GForce-PD members also discussed how they can improve outreach and be of better service to the Parkinson's disease (PD) community and help them to make the best possible decisions when pursuing stem cell treatments.}},
  author       = {{Parmar, Malin and Takahashi, Jun and Studer, Lorenz and Barker, Roger A}},
  issn         = {{2373-8057}},
  language     = {{eng}},
  month        = {{02}},
  publisher    = {{Springer Nature}},
  series       = {{npj Parkinson's Disease}},
  title        = {{GFORCE-PD still going strong in 2016}},
  url          = {{http://dx.doi.org/10.1038/npjparkd.2016.14}},
  doi          = {{10.1038/npjparkd.2016.14}},
  volume       = {{3}},
  year         = {{2017}},
}